KRAS and familial pancreatic carcinoma: Specifically, a high expression level of Kras significantly enhanced the drug resistance of pancreatic cancer cell lines, while simultaneous knockdown of MACC1-AS1 remarkably reversed the drug resistance (Fig. 6B, C).